<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Moreover Technologies - Pharma industry news - 30 of 23204 returned</title>
    <link>http://www.moreover.com/rss</link>
    <description>Moreover Technologies - Real-time news and blogs from thousands of sources</description>
    <language>en-us</language>
    <image>
      <title>Moreover Technologies</title>
      <url>http://i.moreover.com/pics/rss.gif</url>
      <link>http://www.moreover.com/rss</link>
      <width>144</width>
      <height>16</height>
      <description>Moreover Technologies - Premier purveyor of real-time news and RSS feeds from across the Web</description>
    </image>
    <item>
      <title>Acai Berry SHOCKER (Health News 6) - Sponsored Link</title>
      <link>http://context4.kanoodle.com/cgi-bin/rss_query_image.cgi?a=click&amp;bid_id=92288987&amp;creative=242373&amp;clickid=87877635&amp;format=xml1&amp;cgroup=pharmaindustrynews&amp;query=general%20network&amp;ts=ad20100210000000</link>
      <description>Ad - Will Acai Berry Really Help You Lose Fat? Read Our Special Report</description>
      <guid isPermaLink="false">ad20100210000000</guid>
      <pubDate>Wed, 10 Feb 2010 03:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility</title>
      <link>http://c.moreover.com/click/here.pl?r2538145997</link>
      <description>PITTSBURGH, Feb. 9 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Greensboro, N.C., distribution facility has received Verified-Accredited Wholesale Distributors® (VAWD) accreditation from the National Association of Boards</description>
      <guid>http://c.moreover.com/click/here.pl?r2538145997</guid>
      <pubDate>Wed, 10 Feb 2010 03:15:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Austin%20Business%20Journal&amp;o=rss002">Austin Business Journal</source>
    </item>
    <item>
      <title>Amgen's denosumab offers hop</title>
      <link>http://c.moreover.com/click/here.pl?r2538143062</link>
      <description>Extract not available.</description>
      <guid>http://c.moreover.com/click/here.pl?r2538143062</guid>
      <pubDate>Wed, 10 Feb 2010 03:13:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Selftrade%20Investments&amp;o=rss002">Selftrade Investments</source>
    </item>
    <item>
      <title>Debiopharm Group signs licensing agreement with Novartis for Debio 025 for hepatitis C</title>
      <link>http://c.moreover.com/click/here.pl?r2538126065</link>
      <description>Swiss biopharmaceutical company Debiopharm Group declared on Tuesday that it has entered into an exclusive licence agreement with Novartis (NYSE:NVS) for the development, manufacture and commercialisation of Debio 025 (alisporivir). According to</description>
      <guid>http://c.moreover.com/click/here.pl?r2538126065</guid>
      <pubDate>Wed, 10 Feb 2010 03:03:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Individual.com&amp;o=rss002">Individual.com</source>
    </item>
    <item>
      <title>Amgen (AMGN) Appears On Investors Observer Analysts Favorites List</title>
      <link>http://c.moreover.com/click/here.pl?r2538124657</link>
      <description>Amgen (NASDAQ: AMGN) closed yesterday at $57.46. So far the stock has hit a 52-week low of $44.96 and 52-week high of $64.76. Amgen stock has been showing support around 56.14 and resistance in the 58.58 range. Technical indicators for the stock are</description>
      <guid>http://c.moreover.com/click/here.pl?r2538124657</guid>
      <pubDate>Wed, 10 Feb 2010 03:03:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Individual.com&amp;o=rss002">Individual.com</source>
    </item>
    <item>
      <title>OSI Pharmaceuticals (OSIP) Makes Investors Observer Momentum Plays List</title>
      <link>http://c.moreover.com/click/here.pl?r2538124494</link>
      <description>OSI Pharmaceuticals (NASDAQ: OSIP) closed yesterday at $34.17. So far the stock has hit a 52-week low of $27.01 and 52-week high of $42.44. OSI Pharmaceuticals stock has been showing support around 33.71 and resistance in the 34.87 range. Technical</description>
      <guid>http://c.moreover.com/click/here.pl?r2538124494</guid>
      <pubDate>Wed, 10 Feb 2010 03:02:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Individual.com&amp;o=rss002">Individual.com</source>
    </item>
    <item>
      <title>Merck (MRK) Gets 4 Star Buy Rating From S&amp;P With 3.9% Dividend Yield</title>
      <link>http://c.moreover.com/click/here.pl?r2538122974</link>
      <description>Merck (NYSE: MRK) ended the last trading session at $36.73. So far the stock has hit a 52-week low of $20.05 and 52-week high of $41.56. Merck stock has been showing support around 35.28 and resistance in the 37.80 range. Technical indicators for the</description>
      <guid>http://c.moreover.com/click/here.pl?r2538122974</guid>
      <pubDate>Wed, 10 Feb 2010 03:02:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Individual.com&amp;o=rss002">Individual.com</source>
    </item>
    <item>
      <title>Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility</title>
      <link>http://c.moreover.com/click/here.pl?r2538117908</link>
      <description>PR Newswire PITTSBURGH, Feb. 9 PITTSBURGH, Feb. 9 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Greensboro, N.C., distribution facility has received Verified-Accredited Wholesale Distributors® (VAWD) accreditation from the</description>
      <guid>http://c.moreover.com/click/here.pl?r2538117908</guid>
      <pubDate>Wed, 10 Feb 2010 02:59:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Twin%20Cities%20Business%20Journal&amp;o=rss002">Twin Cities Business Journal</source>
    </item>
    <item>
      <title>ISTA Pharmaceuticals Guides Revenue In-line</title>
      <link>http://c.moreover.com/click/here.pl?r2538117735</link>
      <description>Extract not available.</description>
      <guid>http://c.moreover.com/click/here.pl?r2538117735</guid>
      <pubDate>Wed, 10 Feb 2010 02:59:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Individual.com&amp;o=rss002">Individual.com</source>
    </item>
    <item>
      <title>pharmaceutical</title>
      <link>http://c.moreover.com/click/here.pl?r2538112719</link>
      <description>PHARMACEUTICALS covers patent-protected prescription medicines, with news relating to drugmakers, their financial performance, licensing, research and merger &amp;amp; acquisition activities. This also reports on health care markets, patent developments,</description>
      <guid>http://c.moreover.com/click/here.pl?r2538112719</guid>
      <pubDate>Wed, 10 Feb 2010 02:57:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Pharma%20Letter&amp;o=rss002">Pharma Letter</source>
    </item>
    <item>
      <title>Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility</title>
      <link>http://c.moreover.com/click/here.pl?r2538111276</link>
      <description>PR Newswire PITTSBURGH, Feb. 9 PITTSBURGH, Feb. 9 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Greensboro, N.C., distribution facility has received Verified-Accredited Wholesale Distributors® (VAWD) accreditation from the</description>
      <guid>http://c.moreover.com/click/here.pl?r2538111276</guid>
      <pubDate>Wed, 10 Feb 2010 02:56:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Houston%20Business%20Journal&amp;o=rss002">Houston Business Journal</source>
    </item>
    <item>
      <title>Cumberland Pharmaceuticals, Inc. (CPIX) Corporate Event Announcem...</title>
      <link>http://c.moreover.com/click/here.pl?r2538097960</link>
      <description>Cumberland Pharmaceuticals, Inc. (CPIX) Corporate Event Announcement Notice Feb 09, 2010 (Wall Street Horizon via COMTEX) -- Companies: Cumberland Pharmaceuticals Inc (CPIX), Cumberland Pharmaceuticals Inc (CPIX) Expected next earnings release:</description>
      <guid>http://c.moreover.com/click/here.pl?r2538097960</guid>
      <pubDate>Wed, 10 Feb 2010 02:49:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Zibb&amp;o=rss002">Zibb</source>
    </item>
    <item>
      <title>AstraZeneca gets OK for expanded Crestor use</title>
      <link>http://c.moreover.com/click/here.pl?r2538091456</link>
      <description>Extract not available.</description>
      <guid>http://c.moreover.com/click/here.pl?r2538091456</guid>
      <pubDate>Wed, 10 Feb 2010 02:44:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Cleveland%20Live&amp;o=rss002">Cleveland Live</source>
    </item>
    <item>
      <title>Drug problems: Pharmaceutical companies can go too far</title>
      <link>http://c.moreover.com/click/here.pl?r2538088379</link>
      <description>With the upset victory of Republican Scott Brown in the Massachusetts special election last month, Democrats lost their 60-40 filibuster-proof Senate majority, which poses major problems for the timely passage of a much-needed health care overhaul. But</description>
      <guid>http://c.moreover.com/click/here.pl?r2538088379</guid>
      <pubDate>Wed, 10 Feb 2010 02:42:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Houston%20Chronicle&amp;o=rss002">Houston Chronicle</source>
    </item>
    <item>
      <title>Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation</title>
      <link>http://c.moreover.com/click/here.pl?r2538082858</link>
      <description>Extract not available.</description>
      <guid>http://c.moreover.com/click/here.pl?r2538082858</guid>
      <pubDate>Wed, 10 Feb 2010 02:39:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Boston%20Business%20Journal&amp;o=rss002">Boston Business Journal</source>
    </item>
    <item>
      <title>Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation</title>
      <link>http://c.moreover.com/click/here.pl?r2538080256</link>
      <description>Extract not available.</description>
      <guid>http://c.moreover.com/click/here.pl?r2538080256</guid>
      <pubDate>Wed, 10 Feb 2010 02:38:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Cincinnati%20Business%20Journal&amp;o=rss002">Cincinnati Business Journal</source>
    </item>
    <item>
      <title>Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation</title>
      <link>http://c.moreover.com/click/here.pl?r2538079981</link>
      <description>Extract not available.</description>
      <guid>http://c.moreover.com/click/here.pl?r2538079981</guid>
      <pubDate>Wed, 10 Feb 2010 02:38:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Denver%20Business%20Journal&amp;o=rss002">Denver Business Journal</source>
    </item>
    <item>
      <title>Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility</title>
      <link>http://c.moreover.com/click/here.pl?r2538078343</link>
      <description>PITTSBURGH, Feb. 9 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Greensboro, N.C., distribution facility has received Verified-Accredited Wholesale Distributors® (VAWD) accreditation from the National Association of Boards</description>
      <guid>http://c.moreover.com/click/here.pl?r2538078343</guid>
      <pubDate>Wed, 10 Feb 2010 02:37:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Washington%20Business%20Journal&amp;o=rss002">Washington Business Journal</source>
    </item>
    <item>
      <title>Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility</title>
      <link>http://c.moreover.com/click/here.pl?r2538076216</link>
      <description>PITTSBURGH, Feb. 9 PITTSBURGH, Feb. 9 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Greensboro, N.C., distribution facility has received Verified-Accredited Wholesale Distributors® (VAWD) accreditation from the National</description>
      <guid>http://c.moreover.com/click/here.pl?r2538076216</guid>
      <pubDate>Wed, 10 Feb 2010 02:35:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Pittsburgh%20Business%20Times&amp;o=rss002">Pittsburgh Business Times</source>
    </item>
    <item>
      <title>FDA Seeks Reduction in Radiation From Medical Scans</title>
      <link>http://c.moreover.com/click/here.pl?r2538060815</link>
      <description>The U.S. Food and Drug Administration unveiled a plan Tuesday to reduce radiation exposure from three types of increasingly widespread imaging procedures: computed tomography (CT), nuclear medicine studies and fluoroscopy.</description>
      <guid>http://c.moreover.com/click/here.pl?r2538060815</guid>
      <pubDate>Wed, 10 Feb 2010 02:26:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Health.com&amp;o=rss002">Health.com</source>
    </item>
    <item>
      <title>MoU for modernisation of pharma industry</title>
      <link>http://c.moreover.com/click/here.pl?r2538059469</link>
      <description>By our correspondent PESHAWAR: Sarhad Chamber of Commerce and Industry (SCCI) and Pakistan Scientific and Technological Information Centre (PASTIC) have agreed on signing a memorandum of understanding to put pharmaceutical and other industries on modern</description>
      <guid>http://c.moreover.com/click/here.pl?r2538059469</guid>
      <pubDate>Wed, 10 Feb 2010 02:25:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=The%20News%20International&amp;o=rss002">The News International</source>
    </item>
    <item>
      <title>Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 ...</title>
      <link>http://c.moreover.com/click/here.pl?r2538057086</link>
      <description>Anthera Pharmaceuticals announced that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute</description>
      <guid>http://c.moreover.com/click/here.pl?r2538057086</guid>
      <pubDate>Wed, 10 Feb 2010 02:24:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=PipelineReview&amp;o=rss002">PipelineReview</source>
    </item>
    <item>
      <title>Zacks Sell List Highlights: BancorpSouth, Inc., Aetna Inc., GlaxoSmithKline plc and Airgas, Inc.</title>
      <link>http://c.moreover.com/click/here.pl?r2538050435</link>
      <description>CHICAGO--(BUSINESS WIRE)--Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): BancorpSouth, Inc. (NYSE:</description>
      <guid>http://c.moreover.com/click/here.pl?r2538050435</guid>
      <pubDate>Wed, 10 Feb 2010 02:21:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Yahoo%21%20Canada&amp;o=rss002">Yahoo! Canada</source>
    </item>
    <item>
      <title>Medical Expert Available Regarding FDA Expanding Rosuvastatin Use to People with Normal LDL Cholesterol</title>
      <link>http://c.moreover.com/click/here.pl?r2538045513</link>
      <description>Source:  Methodist Hospital, Houston Expert Available Christie M. Ballantyne, M.D. Director, Center for Cardiovascular Disease Prevention Methodist DeBakey Heart &amp; Vascular Center in Houston Dr. Christie Ballantyne is one of the world’s foremost</description>
      <guid>http://c.moreover.com/click/here.pl?r2538045513</guid>
      <pubDate>Wed, 10 Feb 2010 02:17:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Newswise&amp;o=rss002">Newswise</source>
    </item>
    <item>
      <title>Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation</title>
      <link>http://c.moreover.com/click/here.pl?r2538043785</link>
      <description>POINT RICHMOND, Calif., Feb. 9 /PRNewswire-FirstCall/ --Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that the first patent covering the composition and method of use of Intermezzo® (zolpidem tartrate sublingual tablet), the lead</description>
      <guid>http://c.moreover.com/click/here.pl?r2538043785</guid>
      <pubDate>Wed, 10 Feb 2010 02:17:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Puget%20Sound%20Business%20Journal&amp;o=rss002">Puget Sound Business Journal</source>
    </item>
    <item>
      <title>F.D.A. to Increase Medical Radiation Oversight</title>
      <link>http://c.moreover.com/click/here.pl?r2538043099</link>
      <description>The federal Food and Drug Administration said Tuesday that it would take steps to more stringently regulate three of the most potent forms of medical radiation, including increasingly popular CT scans, some of which deliver the radiation equivalent of</description>
      <guid>http://c.moreover.com/click/here.pl?r2538043099</guid>
      <pubDate>Wed, 10 Feb 2010 02:16:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=New%20York%20Times&amp;o=rss002">New York Times</source>
    </item>
    <item>
      <title>After a 12-year tenure at IBLF, Adrian Hodges moves to GlaxoSmithKline</title>
      <link>http://c.moreover.com/click/here.pl?r2538040897</link>
      <description>Adrian Hodges is joining GlaxoSmithKline (GSK), a long-standing IBLF partner, to head its Corporate Responsibility &amp; Community Partnerships function. From the time Adrian joined the IBLF leadership team in 1997, he has seen significant changes in the</description>
      <guid>http://c.moreover.com/click/here.pl?r2538040897</guid>
      <pubDate>Wed, 10 Feb 2010 02:15:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=International%20Business%20Leaders%20Forum&amp;o=rss002">International Business Leaders Forum</source>
    </item>
    <item>
      <title>GlaxoSmithKline South Africa uses IBCs to improve quality and efficiency</title>
      <link>http://c.moreover.com/click/here.pl?r2538040542</link>
      <description>Got a Question for Matcon IBC? Matcon IBC Fax: 02 9892 4844 Unit 4, 181 McCredie Rd Guildford West NSW 2161 Visit WebsiteEnquire Now GSK South Africa in Cape Town manufactures Albendazole Tablets, which have been remarkably successful in the treatment of</description>
      <guid>http://c.moreover.com/click/here.pl?r2538040542</guid>
      <pubDate>Wed, 10 Feb 2010 02:15:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Ferret.com.au&amp;o=rss002">Ferret.com.au</source>
    </item>
    <item>
      <title>Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility</title>
      <link>http://c.moreover.com/click/here.pl?r2538032365</link>
      <description>PITTSBURGH, Feb. 9 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Greensboro, N.C., distribution facility has received Verified-Accredited Wholesale Distributors® (VAWD) accreditation from the National Association of Boards</description>
      <guid>http://c.moreover.com/click/here.pl?r2538032365</guid>
      <pubDate>Wed, 10 Feb 2010 02:09:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Business%20Journal%20of%20Jacksonville&amp;o=rss002">Business Journal of Jacksonville</source>
    </item>
    <item>
      <title>Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation</title>
      <link>http://c.moreover.com/click/here.pl?r2538028381</link>
      <description>Extract not available.</description>
      <guid>http://c.moreover.com/click/here.pl?r2538028381</guid>
      <pubDate>Wed, 10 Feb 2010 02:08:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Los%20Angeles%20Business&amp;o=rss002">Los Angeles Business</source>
    </item>
    <item>
      <title>AIS Introduces a Open Standard PC-Based Process Automation System featuring an Fully Rugged Design and HMI Operator Interface Technology for Industrial, Chemical, Pharmaceutical and Biotech Industries</title>
      <link>http://c.moreover.com/click/here.pl?r2538019252</link>
      <description>IRVINE, CA -- American Industrial Systems Inc. (AIS), has introduced a line of Full IP65/NEMA 4 Rated Weatherproof LCD Computers for superior performance in wet, dusty, rugged, and humid environments. Several completely fanless system options are</description>
      <guid>http://c.moreover.com/click/here.pl?r2538019252</guid>
      <pubDate>Wed, 10 Feb 2010 02:03:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Industrial%20Embedded%20Systems&amp;o=rss002">Industrial Embedded Systems</source>
    </item>
  </channel>
</rss>
 